News & Press Releases
Filter by:
‘There’s Going to Be a Learning Curve for Everyone’ – Mintz’s Gutman on Biosimilar Streamlining
June 4, 2026
Life Sciences Litigation Chair and Patent Litigation Co-chair Sige Gutman, recently spoke with Generics Bulletin about the impact of biosimilar streamlining on development, competition, and IP strategy.
Mintz earned recognition for 43 practices and 85 attorneys in the 2026 edition of Chambers USA. Among this year’s results, 14 attorneys and six practice areas received Chambers’ highest distinction, Band 1. Mintz Insurance Practice Chair Nancy Adams was also named a “Star Individual,” a rare designation awarded to lawyers with exceptional recommendations in their field. The firm further expanded its rankings with newly recognized practices and attorneys ranked for the first time or in additional categories.
Mintz Advising on $215 Million Private Placement Concurrent with Avenzo Therapeutics’ and Rallybio’s Merger Transaction
June 03, 2026
Mintz is advising the placement agents in connection with the $215 million private placement that is expected to close concurrently with the completion of the merger transaction between Avenzo Therapeutics, Inc. and Rallybio Corporation.
Mintz IP Practice Earns 17 Individual and 4 Firmwide Recognitions in the 2026 IAM Patent 1000
June 03, 2026
Mintz’s Intellectual Property Practice earned national recognition in the 2026 edition of IAM Patent 1000: The World’s Leading Patent Practitioners. The guide recognizes Mintz with four firmwide rankings and 17 individual attorney distinctions, including a gold ranking for Michael Renaud, who leads the firm’s IP Division.
Mintz Member Terri Shieh-Newton, PhD, has been named to Forbes’ inaugural 2026 America’s Top Women Lawyers list. The list recognizes women in private practice who have built elite reputations through high-stakes legal work, client impact, and leadership across the profession.
Mintz advised the underwriters in connection with NervGen Pharma’s $60 million public offering of common shares and accompanying warrants.

